Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes

NCT01885260 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: ISIS-GCGRRx - Dose Level 1
DRUG: ISIS-GCGRRx - Dose Level 2
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.